On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
On Feb. 21, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 49 new academic research…
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…
On Oct. 6, 2015, Cancer biologist Dr. John Minna, with the Harold C. Simmons Comprehensive Cancer Center at…
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
On Sept. 2008, a narrow region on chromosome 15 contains genetic variations strongly associated with familial lung cancer,…
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
In 2006, the Winship Cancer Institute received a $7.9 million P01 5-year grant from the Cancer Institute (NCI)…
In 2005, Dr. Michael Mulligan from the University of Washington performed Seattle Cancer Care Alliance’s (SCCA) first video-assisted…
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…
On Apr. 14, 1994, the Alpha-Tocopherol Beta-Carotene (ATBC) Cancer Prevention Study found no benefit from the use of…
In 1994, the American Chemical Society awarded the Priestley Medal to Howard E. Simmons ‘for his numerous contributions…
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
In 1992, the National Cancer Institute (NCI) awarded the Pacific Health Research Institute its largest and most enduring…
In 1988, the U.S. Centers for Disease Control and Prevention (CDC) established the Chronic Disease Division to target…
In 1986, philanthropist Harcourt Sylvester Jr. pledged $27.5 million to benefit cancer programs at the medical school, and…
In 1981, John Wayne Cancer Institute (formerly known as the John Wayne Cancer Clinic) was founded to promote…
On Dec. 19, 1978, the U.S. Food and Drug Administration (FDA) approved cisplatin (Platinol) for use in combination…
In 1976, the U.S. Centers for Disease Control and Prevention (CDC) became the home for the National Clearinghouse…
In 1972, The Wistar Institute was designated the first National Cancer Institute (NCI) Cancer Center in basic research…
On Feb. 27, 1970, in Upjohn v. Finch the Court of Appeals upheld enforcement of the 1962 drug…